|
| Exchange Received Time 01/06/2017 15:54:17 Exchange Disseminated Time 01/06/2017 15:54:22 Time Taken 00:00:05 | Pursuant to Regulation 30 and Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Voting Results (including e-voting), along with the Scrutinizer's Report, of the Tribunal Convened Meeting of the Shareholders of the Company in respect of the Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited and Neuland Health Sciences Private Limited and Neuland Pharma Research Private Limited and their respective Shareholders and Creditors of the Company, held on May 30, 2017.
We would like to further inform that the Resolution set forth in the Notice of the Tribunal Convened Meeting has been passed by the Members of the Company with requisite majority.
|
|
|